174 related articles for article (PubMed ID: 28992239)
1. Investigation of the efficacy and safety of CyberKnife hypofractionated stereotactic radiotherapy for brainstem metastases using a new evaluation criterion: 'symptomatic control'.
Nakamura M; Nishimura H; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Nishikawa R; Sasaki R
J Radiat Res; 2017 Nov; 58(6):834-839. PubMed ID: 28992239
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
3. Brainstem metastases treated with stereotactic radiosurgery: safety, efficacy, and dose response.
Trifiletti DM; Lee CC; Winardi W; Patel NV; Yen CP; Larner JM; Sheehan JP
J Neurooncol; 2015 Nov; 125(2):385-92. PubMed ID: 26341374
[TBL] [Abstract][Full Text] [Related]
4. Utility of graded prognostic assessment in evaluation of patients with brainstem metastases treated with radiosurgery.
Joshi R; Johnson MD; Maitz A; Marvin KS; Olson RE; Grills IS
Clin Neurol Neurosurg; 2016 Aug; 147():30-3. PubMed ID: 27262115
[TBL] [Abstract][Full Text] [Related]
5. Accelerator-based stereotactic radiosurgery for brainstem metastases.
Lin CS; Selch MT; Lee SP; Wu JK; Xiao F; Hong DS; Chen CH; Hussain A; Lee PP; De Salles AA
Neurosurgery; 2012 Apr; 70(4):953-8; discussion 958. PubMed ID: 21997541
[TBL] [Abstract][Full Text] [Related]
6. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma.
Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Swangsilpa T; Sitathanee C; Jiarpinitnun C; Vitoonpanich P; Yongvithisatid P
Technol Cancer Res Treat; 2016 Dec; 15(6):NP10-NP15. PubMed ID: 26424501
[TBL] [Abstract][Full Text] [Related]
9. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
[TBL] [Abstract][Full Text] [Related]
10. Linac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis.
Sugimoto T; Matsuda R; Tamamoto T; Hontsu S; Yamaki K; Miura S; Park YS; Nakase H; Hasegawa M
World Neurosurg; 2019 Dec; 132():e680-e686. PubMed ID: 31442651
[TBL] [Abstract][Full Text] [Related]
11. Treatment of brainstem metastases with gamma-knife radiosurgery.
Sengöz M; Kabalay IA; Tezcanlı E; Peker S; Pamir N
J Neurooncol; 2013 May; 113(1):33-8. PubMed ID: 23443514
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and prognostic factors for patients with brainstem metastases undergoing stereotactic radiosurgery.
Hatiboglu MA; Chang EL; Suki D; Sawaya R; Wildrick DM; Weinberg JS
Neurosurgery; 2011 Oct; 69(4):796-806; discussion 806. PubMed ID: 21508879
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
15. Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.
Croker J; Chua B; Bernard A; Allon M; Foote M
Clin Exp Metastasis; 2016 Feb; 33(2):125-32. PubMed ID: 26482476
[TBL] [Abstract][Full Text] [Related]
16. Gamma Knife radiosurgery in the management of brainstem metastases.
Jung EW; Rakowski JT; Delly F; Jagannathan J; Konski AA; Guthikonda M; Kim H; Mittal S
Clin Neurol Neurosurg; 2013 Oct; 115(10):2023-8. PubMed ID: 23870233
[TBL] [Abstract][Full Text] [Related]
17. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
[TBL] [Abstract][Full Text] [Related]
18. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.
Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC
Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830
[TBL] [Abstract][Full Text] [Related]
19. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
20. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study.
Murai T; Ogino H; Manabe Y; Iwabuchi M; Okumura T; Matsushita Y; Tsuji Y; Suzuki H; Shibamoto Y
Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):151-8. PubMed ID: 24332223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
